A DNA vaccine targeting the dengue virus envelope protein domain III to dendritic cells improves humoral and cellular immune responses (2018)
- Authors:
- USP affiliated authors: YAMAMOTO, MARCIO MASSAO - ICB ; FERREIRA, LUIS CARLOS DE SOUZA - ICB ; BOSCARDIN, SILVIA BEATRIZ - ICB
- Unidade: ICB
- DOI: 10.1002/eji.201871000
- Subjects: PARASITOLOGIA; VACINAS VIRAIS; DENGUE; CÉLULAS DENDRÍTICAS; IMUNOLOGIA CELULAR; PROTEÍNAS; DNA VIRAL
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher: Wiley - V C H Verlag GmbH & Co. KGaA
- Publisher place: Weinheim
- Date published: 2018
- Source:
- Título: European Journal of Immunology
- ISSN: 1521-4141
- Volume/Número/Paginação/Ano: v. 48, supl. 1, p. 1-193, 2018
- Conference titles: International Symposium on Dentritic Cells
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
BARUEL ZANETI, A. et al. A DNA vaccine targeting the dengue virus envelope protein domain III to dendritic cells improves humoral and cellular immune responses. European Journal of Immunology. Weinheim: Wiley - V C H Verlag GmbH & Co. KGaA. Disponível em: https://doi.org/10.1002/eji.201871000. Acesso em: 30 mar. 2026. , 2018 -
APA
Baruel Zaneti, A., Massao Yamamoto, M., Bandeira Sulczewski, F., da Silva Almeida, B., Santos Souza, H. F., Silva Sale , N., et al. (2018). A DNA vaccine targeting the dengue virus envelope protein domain III to dendritic cells improves humoral and cellular immune responses. European Journal of Immunology. Weinheim: Wiley - V C H Verlag GmbH & Co. KGaA. doi:10.1002/eji.201871000 -
NLM
Baruel Zaneti A, Massao Yamamoto M, Bandeira Sulczewski F, da Silva Almeida B, Santos Souza HF, Silva Sale N, Ferreira LC de S, Boscardin SB. A DNA vaccine targeting the dengue virus envelope protein domain III to dendritic cells improves humoral and cellular immune responses [Internet]. European Journal of Immunology. 2018 ; 48 1-193.[citado 2026 mar. 30 ] Available from: https://doi.org/10.1002/eji.201871000 -
Vancouver
Baruel Zaneti A, Massao Yamamoto M, Bandeira Sulczewski F, da Silva Almeida B, Santos Souza HF, Silva Sale N, Ferreira LC de S, Boscardin SB. A DNA vaccine targeting the dengue virus envelope protein domain III to dendritic cells improves humoral and cellular immune responses [Internet]. European Journal of Immunology. 2018 ; 48 1-193.[citado 2026 mar. 30 ] Available from: https://doi.org/10.1002/eji.201871000 - Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge
- Type 1 and 2 mouse spleen conventional dendritic cells differentially prime T helper cells after antigen targeting via DEC205 and DCIR2 receptors
- HIV Envelope Trimer Specific Immune Response Is Influenced by Different Adjuvant Formulations and Heterologous Prime-Boost
- Cytotoxic anti-circumsporozoite antibodies target malaria sporozoites in the host skin
- Antigen targeting to dendritic cells allows the identification of a CD4 T-cell epitope within an immunodominant Trypanosoma cruzi antigen
- CpG oligodeoxinucleotides and flagellin modulate the immune response to antigens targeted to CD8 alpha(+) and CD8 alpha(-) conventional dendritic cell subsets
- CD8+ T cell adjuvant effects of Salmonella FliCd flagellin in live vaccine vectors or as purified protein
- The dengue virus non-structural 1 protein: risks and benefits
- Adjuvant-mediated epitope specificity and enhanced neutralizing activity of antibodies targeting dengue virus envelope protein
- The presence of T cell epitopes is important for induction of antibody responses against antigens directed to DEC205+ dendritic cells
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
